Vaxart (STU:NB11) Common Stock: €0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:NB11 Vaxart Inc STU:NB11
49 GF Score
Price €0.60
! 3 Warning Signs
View Full Analysis

What is Vaxart Common Stock?

Vaxart STU:NB11 49 Common Stock is €0.0 Mil as of Mar. 2026. GuruFocus rates STU:NB11 with a GF Score™ of 49/100. The stock has 3 warning signs investors should review.

Vaxart's quarterly common stock stayed the same from Sep. 2025 (€0.0 Mil) to Dec. 2025 (€0.0 Mil) but then increased from Dec. 2025 (€0.0 Mil) to Mar. 2026 (€0.0 Mil).

Vaxart's annual common stock increased from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.0 Mil) but then declined from Dec. 2024 (€0.0 Mil) to Dec. 2025 (€0.0 Mil).

Vaxart Common Stock Historical Data

* Premium members only.

The historical data trend for Vaxart's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxart Common Stock Chart

Vaxart Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.01 0.02 0.02

Vaxart Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.02
STU:NB11
49GF Score
Vaxart Inc STU:NB11
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxart Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.0 Mil mean?
Vaxart (STU:NB11) has a Common Stock of €0.0 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Vaxart and its competitors.
Is Vaxart's Common Stock too high?
Vaxart's current Common Stock is €0.0 Mil. Overall, Vaxart has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Vaxart's Common Stock compare to VTVT and SPRB?
Vaxart's Common Stock of €0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Vaxart and its competitors. Vaxart's current Common Stock is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxart stock overvalued right now?
Vaxart (STU:NB11) has a current Common Stock of €0.0 Mil. The current Common Stock is €0.0 Mil. Vaxart's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Vaxart (STU:NB11), the current Common Stock is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaxart Business Description

Other Exchanges VXRT:USA
Address 170 Harbor Way, Suite 300, South San Francisco, CA, USA, 94080
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically, all the business activity functions through the region of the United States.
49GF Score

Get the complete analysis for STU:NB11

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.60
Price